Kume K. Flexible robotic endoscopy for treating gastrointestinal neoplasms. World J Gastrointest Endosc 2023; 15(6): 434-439 [PMID: 37397973 DOI: 10.4253/wjge.v15.i6.434]
Corresponding Author of This Article
Keiichiro Kume, MD, PhD, Associate Professor, Third Department of Internal Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 8078555, Japan. k-kume@med.uoeh-u.ac.jp
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Endosc. Jun 16, 2023; 15(6): 434-439 Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.434
Flexible robotic endoscopy for treating gastrointestinal neoplasms
Keiichiro Kume
Keiichiro Kume, Third Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu 8078555, Japan
Author contributions: Kume K conceived of, designed, prepared and wrote this review.
Supported byGrant-in-Aid for Scientific Research (KAKENHI), No. 23500573, No. 263500554, No. 17K01431 and No. 20K12700; Grant of the Princess Takamatsu Cancer Research Fund, No. 13-24505; and Terumo Life Science Foundation, No. 15-I101 and No. 20-III119.
Conflict-of-interest statement: Dr. Kume reports grants from Grant-in-Aid for Scientific Research, grants from Grant of the Princess Takamatsu Cancer Research Fund, grants from Terumo Foundation for Life and Arts, during the conduct of the study; In addition, Dr. Kume has a patent in Japan. No. 5605613 issued, and a patent in Japan No. 5880952 was issued.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Keiichiro Kume, MD, PhD, Associate Professor, Third Department of Internal Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 8078555, Japan. k-kume@med.uoeh-u.ac.jp
Received: December 21, 2022 Peer-review started: December 21, 2022 First decision: April 13, 2023 Revised: April 14, 2023 Accepted: May 4, 2023 Article in press: May 4, 2023 Published online: June 16, 2023 Processing time: 175 Days and 0.8 Hours
Abstract
Therapeutic flexible endoscopic robotic systems have been developed primarily as a platform for endoscopic submucosal dissection (ESD) in the treatment of early-stage gastrointestinal cancer. Since ESD can only be performed by highly skilled endoscopists, the goal is to lower the technical hurdles to ESD by introducing a robot. In some cases, such robots have already been used clinically, but they are still in the research and development stage. This paper outlined the current status of development, including a system by the author’s group, and discussed future challenges.
Core Tip: The current status and future issues in the new standardization that therapeutic flexible endoscopic robotic systems have brought to endoscopic submucosal dissection and endoscopic full-thickness resection were outlined.
